Q4 2023 US MMORPG App Performance on Unified Platform

In the final quarter of 2023, the MMORPG genre continued to captivate gamers across the United States. Sensor Tower's data provides a glimpse into how the top-performing MMORPG applications fared on the unified platform.

Diablo Immortal, published by Blizzard Entertainment, Inc., showed fluctuating revenue through the quarter, peaking at nearly $1M in the week before Christmas. Downloads saw a steady increase, reaching around 17K in the last week of December. Weekly active users showed a slight decline over the quarter, dropping from approximately 346K to 301K.

Sandbox Interactive GmbH's Albion Online displayed consistent revenue figures, hovering around $19K towards the end of December. The game's downloads had an uptick in mid-quarter, with a notable jump to over 13K. Weekly active users experienced growth, particularly in November, but ended the quarter with a slight decrease to just over 12K.

The Legend of Neverland, despite lacking publisher country information, saw its revenue rise sharply to almost $200K in the week of Christmas. Downloads also saw an increase, with a jump to over 12K in the same period. The game's active users peaked at around 97K in late November but saw a general upward trend, concluding the quarter with over 91K.

For Summoners War: Chronicles by Com2uS Corp., revenue trends varied, with a notable rise to over $50K in the last week of December. The game's downloads saw a significant surge in mid-December, hitting around 79K. Active users mirrored this growth, peaking at over 121K in the same week.

Lastly, Fate of the Empress by Wish Interactive Technology Limited demonstrated steady revenue, with a slight increase to over $83K towards the quarter's end. Downloads remained consistent, with a rise to nearly 10K in the last week. The game's weekly active users showed growth, ending the quarter with close to 40K.

For more insights on these trends and other app performance metrics, Sensor Tower's platform offers a comprehensive analysis.